Patent · US Active

Crystalline forms of a potent HCV inhibitor

US8362035B2 · kind B2 · utility

4Cited by

4References

10Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thilo Berkenbusch · Worms, DE
Carl Alan Busacca · Poughkeepsie, US
Burkhard Jaeger · Bingen, DE
Richard J. Varsolona · Scotch Plains, US

Key dates

Filing date	Jul 3, 2012
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Jul 3, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel crystalline forms of the following Compound (1), and the sodium salt thereof, and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.